Late Breaking Clinical Trials 1 PCI, FFR and cost

[LB1-5] Safety of Revascularization Deferral of Left Main Coronary Artery Stenosis Based on FFR and iFR Evaluation: Insights from DEFINE-LM Registry

^○Warisawa Takayuki^1,2, Cook Christopher M.¹, Rajkumar Christopher¹, Howard James P.¹, Seligman Henry¹, Ahmad Yousif¹, Hajj Stephanie El³, Doi Shunichi⁴, Nakajima Akihiro⁵, Nakayama Masafumi^6,7, Goto Sonoka^8,9, Vera-Urquiza Rafael⁸, Takao Takao⁹, Kikuta Yuetsu^1,10, Kawase Yoshiaki¹¹, Nishina Hidetaka¹², Nakamura Sunao⁵, Lerman Amir³, Matsuo Hitoshi¹¹, Francis Darrel P.¹, Escaned Javier⁸, Akashi Yoshihiro J.⁴, Davies Justin E.¹ (1.Cardiovascular Science, Hammersmith Hospital, Imperial College London, London, U.K., 2.Department of Cardiovascular Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital, Yokohama, Japan, 3.Department of Cardiovascular Medicine, Mayo Clinic, Rochester, U.S.A., 4.Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 5.Department of Cardiovascular Medicine, New Tokyo Hospital, Matsudo, Japan, 6.Cardiovascular Centre, Toda Central General Hospital, Toda, Japan, 7.Tokyo Women's Medical University - Waseda University Joint Institution for Advanced Biomedical Sciences, Tokyo, Japan, 8.Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain, 9.Department of Cardiology, Tachikawa General Hospital, Nagaoka, Japan, 10.Division of Cardiology, Fukuyama Cardiovascular Hospital, Fukuyama, Japan, 11.Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan, 12.Department of Cardiology, Tsukuba Medical Center Hospital, Tsukuba, Japan)

同通あり